share_log

Baird Maintains Outperform on Applied Therapeutics, Lowers Price Target to $5

Benzinga ·  02:09  · Ratings

Baird analyst Brian Skorney maintains Applied Therapeutics (NASDAQ:APLT) with a Outperform and lowers the price target from $14 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment